VivoSim Labs, Inc. (VIVS)
VivoSim Labs Market Cap : 3.770M for April 10, 2026
Market Cap Chart
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| ResMed, Inc. | 33.34B |
| Aprea Therapeutics, Inc. | 10.40M |
| ACADIA Pharmaceuticals, Inc. | 3.707B |
| Agenus, Inc. | 151.29M |
| Alnylam Pharmaceuticals, Inc. | 42.72B |
Market Cap Related Metrics
| PE Ratio | 3.015 |
| PS Ratio | 23.77 |
| Price to Book Value | 0.8220 |
| Price | 1.45 |
| Earnings Yield | 33.17% |
| Normalized PE Ratio | 3.016 |